LinkedIn
icn_podcast Podcasts
View All Upcoming Courses
Specialty
Course Type
Search
Login
Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Neuro-Ophthalmology Oculoplastics Optometry Retina Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login
Menu

The Changing Landscape of Neurostimulation in the Treatment of Epilepsy - Enduring

By: Stephanie Chen MSN, MPH, CNRN, FNP-C; Natalya Kan Tyan, BSN, RN, CNRN; Sandipan Pati, MD

Begin Course

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1.25

This webinar focuses on caring for patients with epilepsy and provides up-to-date information on the growing number of treatment options. Topics of discussion include indications for vagal nerve stimulation, responsive neurostimulation, and deep brain stimulation, and how each of those compare for specific patients. The hosts also review and discuss a case study.

Expiration Date: Monday, May 23, 2022
Release Date: May 24, 2021

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Discuss the treatment of refractory epilepsy with neurostimulation including Vagus Nerve Stimulation (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS).
  • Review the surgical work-up for a patient being considered for neurostimulation.
  • Examine when and why VNS vs. DBS. vs RNS is chosen.
  • Discuss nurse teaching points and clinical pearls related to programming each device.

Accreditation and Designation Statement

Provided by Evolve Medical Education 

Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Evolve is approved by the California Board of Registered Nursing, Provider Number 17004, for 1.25 contact hours. 

 

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

Stephanie Chen MSN, MPH, CNRN, FNP-C

Epilepsy Nurse Practitioner

Barrow Neurological Institute

St. Joseph Hospital and Medical Center

Natalya Kan Tyan, BSN, RN, CNRN

Epilepsy Center of Excellence

VA Greater Los Angeles Healthcare System

Sandipan Pati, MD

Neurologist
Associate Professor
Department of Neurology
McGovern Medical School at UT Health

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Stephanie Chen MSN, MPH, CNRN, FNP-C,  has no financial relationships with commercial interests.

Natalya Kan Tyan, BSN, RN, CNRN, has no financial relationships with commercial interests.

Sandipan Pati, MD,  has had a financial agreement or affilitation during the past year with the following commercial interests in the form of Consultant: NeuroPace.

The Evolve staff and planners have no financial relationships with commercial interests.
Bernard M. Abrams, MD, reviewer has no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or NeuroPace, Inc.

Begin Course